BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19100689)

  • 1. Head and neck cancer in the elderly: an overview on the treatment modalities.
    Syrigos KN; Karachalios D; Karapanagiotou EM; Nutting CM; Manolopoulos L; Harrington KJ
    Cancer Treat Rev; 2009 May; 35(3):237-45. PubMed ID: 19100689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck cancer in the elderly: a cohort study in 40 patients.
    Sesterhenn AM; Teymoortash A; Folz BJ; Werner JA
    Acta Oncol; 2005; 44(1):59-64. PubMed ID: 15848907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future chemotherapy and radiotherapy options in head and neck cancer.
    Merlano M; Mattiot VP
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?
    Licitra L; Bossi P; Locati LD
    Curr Opin Oncol; 2006 May; 18(3):253-7. PubMed ID: 16552237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
    Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-operative radiochemotherapy of the head and neck: Towards new standards?].
    Zouhair A; Matzinger O; Azria D; Gaye MP; Ugurluer G; El Hfid M; Mirimanoff RO; Ozsahin M
    Cancer Radiother; 2010 Jun; 14(3):217-21. PubMed ID: 20434385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual patients' data meta-analyses in head and neck cancer.
    Bourhis J; Le MaƮtre A; Baujat B; Audry H; Pignon JP; ; ;
    Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of head and neck cancer in elderly patients: state of the art and guidelines.
    Bernardi D; Barzan L; Franchin G; Cinelli R; Balestreri L; Tirelli U; Vaccher E
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):71-80. PubMed ID: 15607935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for triage in the postoperative management of head and neck cancers.
    Cooper JS; Bernier J
    Oncology (Williston Park); 2005 Jul; 19(8):1011-7; discussion 1018, 1023-4, 1027. PubMed ID: 16131044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly patients with advanced colorectal cancer: which therapy is the safest?
    Rosati G
    Expert Opin Drug Saf; 2005 Nov; 4(6):1041-9. PubMed ID: 16255663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of advanced head and neck squamous cell carcinoma in elderly patients.
    Awada A; de Castro G
    Curr Opin Oncol; 2006 May; 18(3):225-7. PubMed ID: 16552232
    [No Abstract]   [Full Text] [Related]  

  • 14. The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.
    Uygun K; Bilici A; Karagol H; Caloglu M; Cicin I; Aksu G; Fayda M; Uzunoglu S
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):601-5. PubMed ID: 19123002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in radiation therapy of head and neck cancer.
    Popovtzer A; Eisbruch A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):633-44. PubMed ID: 18402530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapies for squamous cell carcinoma of the head and neck.
    Kurtin SE
    Semin Oncol Nurs; 2009 Aug; 25(3):183-92. PubMed ID: 19635397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: overview of randomized trials.
    Bourhis J; Eschwege F
    Anticancer Res; 1996; 16(4C):2397-402. PubMed ID: 8816841
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors.
    Harari PM; Mehta MP; Ritter MA; Petereit DG
    Semin Radiat Oncol; 2003 Jan; 13(1):3-12. PubMed ID: 12520459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.